Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing salmon calcitonin for glioblastoma treatment: Targeting Yes-associated Protein (YAP)/ Transcriptional co‑activator with PDZ‑binding motif (TAZ) via hippo pathway activation.

Neuro-oncology advances·2026
Same author

Separation of Monoclonal Antibody Aggregates Using an Analytical Ultrafiltration Technique.

Membranes·2026
Same author

Localizing the Glycan Binding Sites of SARS-CoV-2 Receptor-Binding Domain.

Analytical chemistry·2026
Same author

Oxidative stress, antioxidant depletion, and DNA damage in post-COVID-19 patients: evidence of a disrupted redox network and loss of age-dependent antioxidant compensation.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Entropy, Free Energy, and a Generalized Order Parameter for Liquid Crystal Phases of Chiral and Achiral Rods.

Journal of chemical theory and computation·2026
Same author

Comparative genomic and proteomic analysis reveals orthogroup structured evolution of tick protease inhibitors.

Comparative biochemistry and physiology. Part D, Genomics & proteomics·2026

Related Experiment Video

Updated: May 18, 2026

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
11:20

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach

Published on: October 16, 2014

Expressing full-length functional PfEMP1 proteins in the HEK293 expression system.

Anand Srivastava1, Yves Durocher, Benoît Gamain

  • 1Institut National de Transfusion Sanguine, Université Paris Diderot, Paris, France.

Methods in Molecular Biology (Clifton, N.J.)
|September 20, 2012
PubMed
Summary

Expressing Plasmodium falciparum proteins like var2CSA is difficult due to genome composition. This study details successful production of the var2CSA protein using a human embryonic kidney expression system for pregnancy-associated malaria research.

More Related Videos

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
11:20

Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach

Published on: October 16, 2014

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Area of Science:

  • Malariology
  • Protein expression
  • Molecular biology

Background:

  • Plasmodium falciparum (P. falciparum) presents challenges for heterologous protein expression due to its AT-rich genome, high cysteine content, and high molecular weight.
  • Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) adhesins are particularly difficult to express, complicating research into malaria pathogenesis.
  • Advancements in synthetic gene synthesis and eukaryotic expression systems enable the expression of complex parasitic proteins.

Purpose of the Study:

  • To describe the methodology for constructing, producing, purifying, and functionally assessing the full-length extracellular region of the var2CSA PfEMP1 protein.
  • To investigate the expression of var2CSA PfEMP1, a key protein in pregnancy-associated malaria (PAM).

Main Methods:

  • Utilized a human embryonic kidney (HEK) expression system for protein production.
  • Detailed the steps for gene synthesis, protein expression, purification strategies, and functional assays.
  • Focused on the full-length extracellular region of the var2CSA PfEMP1 protein.

Main Results:

  • Successfully constructed and produced the full-length extracellular region of var2CSA PfEMP1.
  • Established a protocol for the purification of this high molecular weight, cysteine-rich protein.
  • Demonstrated the feasibility of functional assessment of the expressed protein.

Conclusions:

  • The study successfully demonstrates the expression and purification of the var2CSA PfEMP1 protein using a HEK system.
  • This methodology overcomes previous challenges in expressing complex Plasmodium falciparum proteins.
  • The produced var2CSA protein is suitable for further functional studies relevant to pregnancy-associated malaria.